Li D, Tan A, Hernandez S, Reilly N, Bussberg CJ, Mansfield C. Patient preferences for unresectable hepatocellular carcinoma (HCC) treatments. Poster presented at the 20th Annual International Society of Gastrointestinal Oncology; October 13, 2023. Tempe, AZ. Previously presented at the ESMO 24th World Congress on Gastrointestinal Cancer 2022.
Ravelo A, Myers K, Brumble R, Bussberg C, Koffman B, Manzoor BS, Biondo J, Mansfield C. Understanding patient preferences for chronic lymphocytic leukemia treatments. Poster presented at the 64th ASH Annual Meeting and Exposition; December 12, 2022. New Orleans, LA.
Ervin C, Mangalindan A, Shapouri S, Sutphin J, Mansfield C, Manzoor BS, Sail K, Dine J. What drives treatment preferences in CLL? Listening to the patient voice. Poster presented at the 2021 Virtual iwCLL International Workshop; September 17, 2021.
Mansfield C, Botha W, Vondeling GT, Klein K, Wang K, Singh J, Hackshaw El Khoury M. Patient preferences for HER2-targeted treatment of advanced or metastatic breast cancer in the United States. Poster presented at the 2020 ESMO Virtual Congress; September 17, 2020.
Mansfield C, Myers K, Klein K, Patel J, Nakasato A, Tarhini A. Risk tolerance of melanoma treatments in the adjuvant setting: a patient perspective. Poster presented at the 16th International Congress of the Society for Melanoma Research; November 20, 2019. Salt Lake City, UT.
Srinivas S, Mansfield CA, Sandin R, Hauber AB, Hariharan S, Matczak EM, Pugh AL, Chen C. Exploring the effect of medication features in renal cell carcinoma: a patient preference study. Poster presented at the 2015 Genitourinary Cancers Symposium; February 2015.